Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Smartphone App Improves Blood Pressure Control in Hypertension

By HospiMedica International staff writers
Posted on 17 Sep 2026

Hypertension, or high blood pressure, is a major modifiable driver of cardiovascular, renal, and cerebrovascular morbidity. More...

Despite effective therapies, many adults fail to achieve control, leading to avoidable hospitalizations and high costs. Clinicians need scalable ways to reinforce adherence and healthy behaviors between visits. A new study shows that integrating an AI-enabled smartphone app into routine care plans can help patients achieve meaningful blood pressure reductions.

Clinicians at Rush University Medical Center (Chicago, IL, USA) evaluated the Nuna app, a free tool developed by Nuna Inc. The app combines AI-driven health coaching, blood pressure tracking, and behavioral incentives with personalized reminders. It is embedded in clinical workflows and gives care teams visibility into patients’ self-management between appointments.

In a yearlong matched cohort study, 425 adults receiving hypertension care at Rush incorporated the app into their treatment. Their systolic and diastolic blood pressures were monitored for six months and compared with baseline readings from the prior six months. Outcomes were assessed against a demographically similar control group of 425 patients who received standard care without the app.

Both groups improved, but app users achieved greater reductions, particularly among those with uncontrolled disease at baseline. In participants with uncontrolled stage 2 hypertension, systolic blood pressure fell by 13.6 mmHg with the app versus 9.0 mmHg in controls. Patients who used the app weekly had roughly 2.5 times the odds of achieving controlled blood pressure at six months compared with less frequent users. Engagement was sustained, with 87% of patients still using the app at six months and about three quarters using it weekly.

Findings were published in the Journal of General Internal Medicine on September 9, 2026. Rush has since expanded use of the app to more than 1,700 patients for hypertension, prediabetes, diabetes, and related cardiometabolic comorbidities. Broader adoption may be supported by the Centers for Medicare and Medicaid Innovation’s ACCESS model, which reimburses technologies that help manage chronic conditions; the developer participates in this program.

“The group that incorporated the Nuna app into their care showed clinically significant improvements. While the study wasn't designed to assess hard clinical outcomes, established research has shown a direct correlation between reductions of this magnitude and lower rates of heart attacks and strokes,” said Michael Gottlieb, M.D., M.B.A., a Rush emergency medicine physician, vice chair of research and the study’s co-lead author. "But well before we were able to process and assess the impact of the app as researchers, as physicians we were able to see—patient by patient—the power of a tool that empowers patients to manage their blood pressure every day."

“Nuna helps us understand what happens outside of the clinic walls. It's not a snapshot in time like a clinic visit, but rather a window into a patient's daily routine and blood pressure control progress. We know long-term damage from cardiovascular disease is an accumulation of your risk over time, and now we can communicate more proactive treatment adjustments faster. Instead of lowering a patient's risk over a period of months, we can do it in weeks,” said Kristin Pallok, M.D., a Rush internal medicine specialist and the study’s co-lead author.

Related Links
Rush University Medical Center


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Fetal Monitor
BT-380
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: Overview of the study design, including participant recruitment, multimodal neuroimaging analysis, stage- and cognition-informed feature selection, and development and validation of the DBFG-Net model. CKD-CI, CKD with cognitive impairment; CKD-NCI, CKD without cognitive impairment; HCs, healthy controls; CBF, cerebral blood flow; DBFG-Net, Dual-Branch Feature-Gated Network. (Photo courtesy of Wenbo Yang and Lijun Song, Capital Medical University)

AI Combines Brain Imaging Features to Identify Cognitive Impairment in CKD

Chronic kidney disease (CKD) can affect multiple organs, including the brain, with cognitive impairment emerging as a common complication. Changes in executive function, attention, and memory can reduce... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.